Views: 0 Author: Site Editor Publish Time: 2025-04-01 Origin: Site
In the field of biopharmaceutical research, accurate and reproducible animal models are critical for preclinical drug evaluation. Shinova Medical Co., Ltd., a pioneer in veterinary medical technology, has developed a professional-grade device specifically designed for research institutions: the Mice Colonoscope. This tool focuses on enhancing the reliability of rectal disease modeling in mice, enabling dynamic assessment of drug efficacy, safety, and disease progression.
Stable and reproducible rectal disease models, such as colitis and colorectal tumors, are essential for effective drug screening. Traditionally, this involved sacrificing animals at different time points for tissue analysis. The Shinova Mice Colonoscope replaces this approach with 4K ultra-high-definition imaging and multispectral LED lighting, allowing researchers to observe microstructural mucosal changes in vivo, including:
Inflammatory response tracking
Tumor growth monitoring
Drug-induced pathological changes
4K Ultra-HD Camera: Enables real-time visualization of living tissue responses.
360° Rotatable Lens: Allows thorough inspection of affected regions.
Multispectral LED Illumination: Enhances contrast in low-light conditions for accurate evaluation.
This advanced imaging technology supports precise evaluation of animal models, which directly improves the accuracy of drug efficacy studies.
To ensure longitudinal data collection, the Mice Colonoscope features an ultra-thin flexible probe (<2mm diameter) that minimizes harm to the rectal tissue. This design enables repeated observation of the same group of animals, reducing variability and complying with the 3Rs Principle (Replacement, Reduction, Refinement) in animal research.
Observe how drugs impact mucosal integrity over time
Track healing or degeneration trends in chronic disease models
Improve reproducibility of results by reducing sample loss
Animal-Friendly Design: Minimizes stress during experimentation
Longitudinal Observation: Supports multi-stage evaluation within the same cohort
3Rs Compliance: Reduces animal use and enhances ethical research standards
The colonoscope is equipped with a modular biopsy system, enabling researchers to extract tissue samples during live observation. This allows histopathological, transcriptomic, or metabolomic analysis to be directly linked to visual imaging data, improving model validation and experimental integrity.
Toxicity Analysis: Monitor epithelial cell damage from drug metabolites
Gene Therapy Monitoring: Observe rectal repair post-CRISPR modification
Microbiome Studies: Evaluate microbiota changes via minimally invasive sampling
In a preclinical study of anti-inflammatory drugs, researchers used the colonoscope to monitor colitis development and drug responses in a live animal model. This continuous, real-time imaging helped detect early-stage mucosal damage, offering a more sensitive and ethical approach than traditional necropsy.
While originally designed for gastrointestinal research, the Mice Colonoscope now plays a vital role in drug development pipelines, particularly for:
Disease Modeling: Establish and validate animal models of IBD and colorectal cancer
Drug Efficacy Testing: Monitor tumor regression or inflammation reduction in response to treatment
Toxicity Studies: Assess intestinal damage from candidate drugs
Mechanism Research: Study immune cell infiltration or tissue regeneration dynamics
These features make it a valuable asset for preclinical researchers aiming for both data precision and ethical compliance.
Research-Focused Design: Customized for small animal modeling and tracking
High-Resolution Imaging + AI Tools: Supports visual data analysis and comparison
Biocompatibility Certified: ISO 10993 certified for minimal animal harm
Widely Trusted: Used by over 200 global pharmaceutical institutions
Full Integration: From imaging to biopsy to data interpretation, all-in-one solution
The Shinova Mice Colonoscope is a groundbreaking tool that empowers researchers to build reliable rectal disease models and perform accurate drug efficacy assessments without sacrificing animal welfare. Through non-invasive imaging, integrated biopsy, and real-time monitoring, it reshapes the way preclinical studies are conducted—enhancing consistency, accuracy, and ethical standards.
To explore detailed case studies, technical whitepapers, or see how this tool can be integrated into your research workflow, visit www.shinovaveterinary.com.